Publications by authors named "Jamila Pitts"
The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising concerns about the efficacy of infection- or vaccine-induced antibodies. We compared antibody binding and live virus neutralization of sera from naturally infected and Moderna-vaccinated individuals against two SARS-CoV-2 variants: B.1 containing the spike mutation D614G and the emerging B.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates how effective antibodies from people who had COVID-19 or were vaccinated respond to new SARS-CoV-2 variants, specifically B.1 and B.1.351.
- Researchers found that both groups showed a notable decrease in antibody levels when confronting the B.1.351 variant compared to the original B.1 variant.
- Despite these reductions, many antibodies still effectively neutralized the B.1.351 variant, indicating that immunity against COVID-19 is still largely maintained.